The Journal of rheumatology

publication venue for

Malar rash in systemic juvenile idiopathic arthritis. 2010
Docetaxel (taxotere) induced subacute cutaneous lupus erythematosus: report of 4 cases. 2004
Systemic lupus erythematosus: calciphylaxis induced cardiomyopathy. 1995
An association between refractory HELLP syndrome and antiphospholipid antibodies during pregnancy; a report of 2 cases. 1994
Subdural hematoma in systemic lupus erythematosus: report and review of the literature. 1987
The Lived Experiences of Older Adults with Systemic Lupus Erythematosus: Patient Perspectives. 2024
Which education topics and smartphone app functions are prioritized by U.S. rheumatology patients? A mixed-methods study. 2024
Systemic sclerosis in individuals with exposure to World Trade Center ground-zero rescue/recovery efforts: A case series. 2024
Advances and Controversies in Our Understanding of Guttate and Plaque Psoriasis.. 50. 2023
Feasibility of Conducting Comparative Effectiveness Research and Validation of a Clinical Disease Activity Score for Chronic Nonbacterial Osteomyelitis. 2023
Measuring what matters: a qualitative study of the relevance and clinical utility of PROMIS® surveys in systemic lupus erythematosus. 2023
Factors Associated With Maintenance of Remission Following Change From Combination Therapy to Monotherapy in Patients With Rheumatoid Arthritis.. 50. 2023
Understanding Differences in Patient Descriptions of Rheumatoid Arthritis Flares Using OMERACT Core Domains.. 50. 2023
B Cell Reconstitution is Associated With COVID-19 Booster Vaccine Responsiveness in Patients Previously Seronegative Treated With Rituximab.. 50. 2022
Canadian Rheumatology Association living guidelines for the pharmacological management of rheumatoid arthritis with disease-modifying anti-rheumatic drugs. 2022
Mammalian Target of Rapamycin Pathway Assessment in Antiphospholipid Antibody Positive Patients with Livedo. 2022
Rho Kinase Expression in Giant Cell Arteritis: Validating pERM Intensity Score to Increase Sensitivity of Temporal Artery Biopsy. 2022
Frequency of Symptomatic Adverse Events in Rheumatoid Arthritis: An Exploratory Online Survey. 2022
Mammalian Target of Rapamycin Pathway Assessment in Antiphospholipid Antibody Positive Patients with Livedo 2022
High Systemic Type I Interferon Activity Is Associated With Active Class III/IV Lupus Nephritis.. 49. 2021
Evaluation of a Patient-Reported Frailty Tool in Women with Systemic Lupus Erythematosus. 2021
Heterogeneity in Patient Characteristics and Differences in Treatment Across 4 Canadian Rheumatoid Arthritis Cohorts.. 49. 2021
Esophageal Dilation and Other Clinical Factors Associated With Pulmonary Function Decline in Patients With Systemic Sclerosis.. 48. 2021
Higher Serum Urate Levels Are Associated With an Increased Risk for Sudden Cardiac Death. 2021
Association of Patients' Familiarity and Perceptions of Efficacy and Risks With the Use of Opioid Medications in the Management of Osteoarthritis. 2021
Esophageal Dilation and Other Clinical Factors Associated with Pulmonary Function Decline in Patients with Systemic Sclerosis 2021
Risk of Adverse Outcomes in Hospitalized Patients With Autoimmune Disease and COVID-19: A Matched Cohort Study From New York City.. 48. 2020
Evaluating Quality of Care for Rheumatoid Arthritis for the Population of Alberta Using System-level Performance Measures.. 48. 2020
"Unspoken Questions": A Qualitative Study of Rheumatologists' Perspectives on the Clinical Implementation of Patient-reported Outcome Measures.. 47. 2020
Trends in the Inpatient Burden of Coronary Artery Disease in Granulomatosis With Polyangiitis: A Study of a Large National Dataset.. 48. 2020
Feasibility and Face Validity of Outcome Measures for Use in Future Studies of Polymyalgia Rheumatica: An OMERACT Study.. 47. 2020
When Has a Knee or Hip Replacement Failed? A Patient Perspective.. 48. 2019
Atrial Fibrillation/flutter Hospitalizations among US Medicaid Recipients with and without Systemic Lupus Erythematosus.. 47. 2019
Correlates of Successful Rheumatoid Arthritis Flare Management: Clinician-driven Treatment, Home-based Strategies, and Medication Change.. 47. 2019
Dissociation Between Clinical Benefit and Persistent Urate Lowering in Patients with Chronic Refractory Gout Treated with Pegloticase.. 47. 2019
Longterm Drug Survival of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis.. 47. 2019
Is Traditional Chinese Medicine Use Associated with Worse Patient-reported Outcomes among Chinese American Rheumatology Patients?. 46. 2019
Physical or Occupational Therapy Use in Systemic Sclerosis: A Scleroderma Patient-centered Intervention Network Cohort Study.. 46. 2019
Neutropenia During Tocilizumab Treatment Is Not Associated with Infection Risk in Systemic or Polyarticular-course Juvenile Idiopathic Arthritis.. 46. 2019
Adaptive Trial Designs in Rheumatology: Report from the OMERACT Special Interest Group.. 46. 2019
Advancing Stiffness Measurement in Rheumatic Disease: Report from the Stiffness Special Interest Group at OMERACT 2018.. 46. 2019
Patient Perspectives on DMARD Safety Concerns in Rheumatology Trials: Results from Inflammatory Arthritis Patient Focus Groups and OMERACT Attendees Discussion.. 46. 2019
Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials.. 46. 2019
HLA-DRB1 Amino Acid Positions and Residues Associated with Antibody-positive Rheumatoid Arthritis in Black South Africans.. 46. 2018
Performance of Forced Vital Capacity and Lung Diffusion Cutpoints for Associated Radiographic Interstitial Lung Disease in Systemic Sclerosis.. 45. 2018
Feasibility of Measurement and Adherence to System Performance Measures for Rheumatoid Arthritis in 5 Models of Care.. 45. 2018
Flares in Patients with Rheumatoid Arthritis after Total Hip and Total Knee Arthroplasty: Rates, Characteristics, and Risk Factors.. 45. 2018
Disparities in Outcomes for Blacks versus Whites Undergoing Total Hip Arthroplasty: A Systematic Literature Review.. 45. 2018
Feasibility, Validity, and Reliability of the 10-item Patient Reported Outcomes Measurement Information System Global Health Short Form in Outpatients with Systemic Lupus Erythematosus.. 45. 2018
Muscle Deficits in Rheumatoid Arthritis Contribute to Inferior Cortical Bone Structure and Trabecular Bone Mineral Density.. 44. 2017
Content and Construct Validity, Reliability, and Responsiveness of the Rheumatoid Arthritis Flare Questionnaire: OMERACT 2016 Workshop Report.. 44. 2017
Validity and Reliability of Patient Reported Outcomes Measurement Information System Computerized Adaptive Tests in Systemic Lupus Erythematosus.. 44. 2017
A Patient-reported Outcome Measure for Effect of Glucocorticoid Therapy in Adults with Inflammatory Diseases Is Needed: Report from the OMERACT 2016 Special Interest Group.. 44. 2017
Proteomic Analysis of Sera from Individuals with Diffuse Cutaneous Systemic Sclerosis Reveals a Multianalyte Signature Associated with Clinical Improvement during Imatinib Mesylate Treatment.. 44. 2017
Reliability and Validity of the Tender and Swollen Joint Counts and the Modified Rodnan Skin Score in Early Diffuse Cutaneous Systemic Sclerosis: Analysis from the Prospective Registry of Early Systemic Sclerosis Cohort.. 44. 2017
Achieving Consensus on Total Joint Replacement Trial Outcome Reporting Using the OMERACT Filter: Endorsement of the Final Core Domain Set for Total Hip and Total Knee Replacement Trials for Endstage Arthritis.. 44. 2017
Gene Expression Profiling in Blood and Affected Muscle Tissues Reveals Differential Activation Pathways in Patients with New-onset Juvenile and Adult Dermatomyositis.. 44. 2016
Patients with Systemic Lupus Erythematosus Have Increased Risk of Short-term Adverse Events after Total Hip Arthroplasty.. 43. 2016
The Recurrence of Digital Ulcers in Patients with Systemic Sclerosis after Discontinuation of Oral Treprostinil.. 43. 2016
The Systemic Juvenile Idiopathic Arthritis Cohort of the Childhood Arthritis and Rheumatology Research Alliance Registry: 2010-2013.. 43. 2016
Identifying Targets for Improving Mental Healthcare of Adolescents with Systemic Lupus Erythematosus: Perspectives from Pediatric Rheumatology Clinicians in the United States and Canada.. 43. 2016
Patients with Rheumatoid Arthritis have Similar Excellent Outcomes after Total Knee Replacement Compared with Patients with Osteoarthritis.. 43. 2015
The Performance and Association Between Patient-reported and Performance-based Measures of Physical Functioning in Research on Individuals with Arthritis.. 43. 2015
Missing Anticitrullinated Protein Antibody Does Not Affect Short-term Outcomes in Early Inflammatory Arthritis: From the Canadian Early Arthritis Cohort.. 42. 2015
14-3-3η Autoantibodies: Diagnostic Use in Early Rheumatoid Arthritis.. 42. 2015
An Internet-based Controlled Trial Aimed to Improve Osteoporosis Prevention among Chronic Glucocorticoid Users.. 42. 2015
Rheumatoid Arthritis Does Not Increase Risk of Short-term Adverse Events after Total Knee Arthroplasty: A Retrospective Case-control Study.. 42. 2015
Predictors of longterm changes in body mass index in rheumatoid arthritis.. 42. 2015
Does socioeconomic status affect outcomes in early inflammatory arthritis? Data from a canadian multisite suspected rheumatoid arthritis inception cohort.. 42. 2014
Earlier time to remission predicts sustained clinical remission in early rheumatoid arthritis--results from the Canadian Early Arthritis Cohort (CATCH).. 41. 2014
Prognosis of seronegative patients in a large prospective cohort of patients with early inflammatory arthritis.. 41. 2014
Serum 14-3-3η is a novel marker that complements current serological measurements to enhance detection of patients with rheumatoid arthritis.. 41. 2014
Patients with rheumatoid arthritis are more likely to have pain and poor function after total hip replacements than patients with osteoarthritis.. 41. 2014
Arthroplasty rates are increased among US patients with systemic lupus erythematosus: 1991-2005.. 41. 2014
Flares in rheumatoid arthritis: frequency and management. A report from the BRASS registry.. 41. 2013
Determining best practices in early rheumatoid arthritis by comparing differences in treatment at sites in the Canadian Early Arthritis Cohort.. 40. 2013
Comparison of the disease activity score using erythrocyte sedimentation rate and C-reactive protein in African Americans with rheumatoid arthritis.. 40. 2013
Associations of alcohol use with radiographic disease progression in African Americans with recent-onset rheumatoid arthritis.. 40. 2013
Variable association of reactive intermediate genes with systemic lupus erythematosus in populations with different African ancestry.. 40. 2013
Clinical response within 12 weeks as a predictor of future low disease activity in patients with early RA: results from the TEAR Trial.. 40. 2013
Patterns and associated risk of perioperative use of anti-tumor necrosis factor in patients with rheumatoid arthritis undergoing total knee replacement.. 40. 2013
Anticitrullinated protein antibodies and rheumatoid factor fluctuate in early inflammatory arthritis and do not predict clinical outcomes.. 40. 2013
Validation of a self-administered inflammatory arthritis detection tool for rheumatology triage.. 40. 2013
Increasing treatment in early rheumatoid arthritis is not determined by the disease activity score but by physician global assessment: results from the CATCH study.. 39. 2012
Time to disease-modifying antirheumatic drug treatment in rheumatoid arthritis and its predictors: a national, multicenter, retrospective cohort.. 39. 2012
Building a rheumatology education academy: insights from assessment of needs during a rheumatology division retreat.. 39. 2012
Genetic ancestry, serum interferon-α activity, and autoantibodies in systemic lupus erythematosus.. 39. 2012
Remission in early rheumatoid arthritis -- a comparison of new ACR/EULAR remission criteria to established criteria.. 39. 2012
Prevalence of annexin A5 resistance in children and adolescents with rheumatic diseases.. 39. 2011
The autoimmune disease risk allele of UBE2L3 in African American patients with systemic lupus erythematosus: a recessive effect upon subphenotypes.. 39. 2011
Safety and effectiveness of rituximab in patients with rheumatoid arthritis following an inadequate response to 1 prior tumor necrosis factor inhibitor: the RESET Trial.. 38. 2011
Early management of newly diagnosed rheumatoid arthritis by Canadian rheumatologists: a national, multicenter, retrospective cohort.. 38. 2011
Emerging issues in pharmacological management of rheumatoid arthritis: results of a national needs assessment survey identifying practice variations for the development of Canadian Rheumatology Association clinical practice recommendations.. 39. 2011
Persistence with anti-tumor necrosis factor therapies in patients with rheumatoid arthritis: observations from the RADIUS registry.. 38. 2011
Relationship between markers of platelet activation and inflammation with disease activity in Wegener's granulomatosis.. 38. 2011
Rheumatoid arthritis disease-modifying antirheumatic drug intervention and utilization study: safety and etanercept utilization analyses from the RADIUS 1 and RADIUS 2 registries.. 38. 2010
Care gap in patients with early inflammatory arthritis with a high fracture risk identified using FRAX(®).. 37. 2010
Using magnetic resonance angiography to measure abnormal synovial blood vessels in early inflammatory arthritis: a new imaging biomarker?. 37. 2010
Causes and predictive factors of mortality in a cohort of patients with hepatitis C virus-related cryoglobulinemic vasculitis treated with antiviral therapy.. 37. 2010
Vitamin D status and its associations with disease activity and severity in African Americans with recent-onset rheumatoid arthritis.. 37. 2009
African Americans and Whites are equally appropriate to be considered for total joint arthroplasty.. 36. 2009
Health-related quality of life and its relationship to patient disease course in childhood-onset systemic lupus erythematosus.. 36. 2009
Comparison of threshold cutpoints and continuous measures of anti-cyclic citrullinated peptide antibodies in predicting future rheumatoid arthritis.. 36. 2009
Smoldering rheumatoid arthritis: is the Canadian healthcare system neglecting a significant disease population?. 35. 2008
Are the 2002 American College of Rheumatology guidelines for the management of rheumatoid arthritis being followed in Canada's largest academic rheumatology center?. 34. 2007
The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic event.. 34. 2007
Antiendothelial cell antibodies in patients with Wegener's granulomatosis: prevalence and correlation with disease activity and manifestations.. 34. 2007
The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus.. 34. 2007
Anti-th/to-positivity in a cohort of patients with idiopathic pulmonary fibrosis.. 33. 2006
Psychosocial variables and fatigue: a longitudinal study comparing individuals with rheumatoid arthritis and healthy controls.. 33. 2006
Can the carpometacarpal joint be injected accurately in the office setting? Implications for therapy.. 33. 2006
Does age bias the aggressive treatment of elderly patients with rheumatoid arthritis?. 32. 2005
Racial disparities in the receipt of osteoporosis related healthcare among community-dwelling older women with arthritis and previous fracture.. 32. 2005
Autocrine activation by interleukin 1alpha induces the fibrogenic phenotype of systemic sclerosis fibroblasts.. 31. 2004
Infusion-related reactions to infliximab in patients with rheumatoid arthritis in a clinical practice setting: relationship to dose, antihistamine pretreatment, and infusion number.. 31. 2004
Is there a difference in the perception of symptoms between african americans and whites with osteoarthritis?. 30. 2003
Defining lupus cases for clinical studies: the Boston weighted criteria for the classification of systemic lupus erythematosus.. 29. 2002
Metacarpophalangeal arthroplasty in rheumatoid arthritis: what determines satisfaction with surgery?. 29. 2002
Pulmonary hypertension in scleroderma spectrum of disease: lack of bone morphogenetic protein receptor 2 mutations.. 29. 2002
Parvoviral infection of endothelial cells and its possible role in vasculitis and autoimmune diseases.. 29. 2002
Combined use of power Doppler and gray-scale sonography: a new technique for the assessment of inflammatory myopathy.. 28. 2001
Primary antiphospholipid syndrome: functional outcome after 10 years.. 27. 2000
Neonatal lupus erythematosus in triplets.. 27. 2000
Interferon-alpha treatment of Behçet's disease.. 25. 1998
Osteonecrosis in the rheumatoid femoral head.. 25. 1998
Enhanced expression of immunoglobulin kappa light chains with unusually long CDR3 regions in patients with rheumatoid arthritis.. 25. 1998
Evaluation of a modified needle for small joint biopsies.. 25. 1998
Clinically occult avascular necrosis of the hip in systemic lupus erythematosus.. 24. 1997
Lack of sensitivity of indium-111 mixed leukocyte scans for active disease in Takayasu's arteritis.. 22. 1995
Beta 2 glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome.. 21. 1994
Characteristics of human immunodeficiency virus and chlorpromazine induced antiphospholipid antibodies: effect of beta 2 glycoprotein I on binding to phospholipid.. 21. 1994
Inhibition of interleukin 1 induced chondrocyte protease activity by a corticosteroid and a nonsteroidal antiinflammatory drug.. 19. 1992
Effects of rheumatoid factor, antinuclear antibodies and plasma reagin on the serologic assay for Lyme disease.. 18. 1991
Should methotrexate be discontinued before elective orthopedic surgery in patients with rheumatoid arthritis?. 18. 1991
Characteristics of IgG antiphospholipid antibodies in patients with systemic lupus erythematosus and syphilis.. 17. 1990
Major salivary gland function in primary Sjögren's syndrome and its relationship to clinical features.. 17. 1990
IgA rheumatoid factor and IgA containing immune complexes in primary Sjögren's syndrome.. 16. 1989
High dose intravenous methotrexate with leucovorin rescue in rheumatoid arthritis.. 15. 1988
Control of collagen synthesis in human chondrocyte cultures by immune interferon and interleukin-1.. 14 Spec No. 1987
Antibody to cardiolipin, lupus anticoagulant, and fetal death.. 14. 1987
Reticuloendothelial system Fc receptor function in the drug induced lupus erythematosus syndrome.. 13. 1986
Reticuloendothelial system fc receptor function in rheumatoid arthritis.. 10. 1983
Education in rheumatology for the primary care physician.. 5. 1978
Anaerobic and aerobic metabolism in articular cartilage.. 4. 1977
The optimal tool for assessment of organ damage in antiphospholipid syndrome.. 40. 2013
Radiographic improvement in sarcoid arthropathy after infliximab treatment.. 39. 2012
Morning stiffness: how common is it and does it correlate with physician and patient global assessment of disease activity?. 28. 2001
Evidence of activation of 2 herpesviruses, Epstein-Barr virus and cytomegalovirus, in systemic sclerosis and normal skins.. 27. 2000
Rheumatology training at the American University of Beirut.. 26. 1999
Silicone breast implants and connective tissue disease.. 21. 1994
IgMk monoclonal antibody directed against peripheral nerve myelin: clinical peripheral neuropathy and longterm rheumatic disease.. 12. 1985
Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #2. 2024
Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #1. 2023
Early spondyloarthritis in an HLA-B27-positive monozygotic twin pair: A highly concordant onset, sites of involvement, and disease course. 2008
Developing a construct to evaluate flares in rheumatoid arthritis: a conceptual report of the OMERACT RA Flare Definition Working Group. 2011
Identifying preliminary domains to detect and measure rheumatoid arthritis flares: report of the OMERACT 10 RA Flare Workshop. 2011
Proposal for levels of evidence schema for validation of a soluble biomarker reflecting damage endpoints in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, and recommendations for study design. 2009
Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the OMERACT 9 v2 criteria. 2009
Fibromyalgia syndrome. 2005
Complementing What We Know About Systemic Lupus Erythematosus Pregnancy. 2023
Keep It in Mind: Assessing the Risk of Dementia in Patients With Rheumatoid Arthritis and Opportunities for Intervention.. 50. 2022
The Effect of COVID-19 Illness on Pregnant Patients With Rheumatic Disease: Early Reassuring Data.. 49. 2021
How Appropriate Are Appropriate-use Criteria?. 46. 2019
Low-dose Glucocorticoid Use Does Not Reduce Biologic Use in Early RA, Nor Do Biologics Reduce the Need for Glucocorticoids.. 46. 2019
Do Recent Trends in RA Surgery Reflect Success in Disease Management?. 45. 2018
Rheumatoid Arthritis Therapy and Joint-replacement Surgery: Are We Making a Difference?. 43. 2016
Radiographic progression in rheumatoid arthritis: does it still happen and does it matter?. 41. 2014
Treating the pain of osteoarthritis--where do we go from here?. 38. 2011
All that glitters is not gold--standardizing diagnosis in rheumatoid arthritis studies.. 38. 2011
Anti-cyclic citrullinated peptide antibody versus HAQ/MDHAQ: comparing apples and oranges?. 36. 2009
A bridge between interferon-alpha and tumor necrosis factor in lupus.. 35. 2008
Lupus and thrombosis.. 33. 2006
Screening for pulmonary hypertension in scleroderma: how and when to look?. 33. 2006
Access to care for rheumatology patients may be compromised: results of a survey to members of the Canadian Rheumatology Association.. 32. 2005
Warfarin in antiphospholipid syndrome--time to explore new horizons.. 32. 2005
The no man's land of undifferentiated inflammatory polyarthritis.. 31. 2004
Rheumatoid arthritis: is the disease becoming milder or is treatment improving?. 31. 2004
Monitoring methotrexate hepatic toxicity in rheumatoid arthritis: is it time to update the guidelines?. 29. 2002
Analysis of the effect of COX-2 specific inhibitors and recommendations for their use in clinical practice.. 27. 2000
What is SLE?. 16. 1989
Canadian recommendations for clinical trials of pharmacologic interventions in rheumatoid arthritis: inclusion criteria and study design. 2011
Canadian recommendations for use of methotrexate in patients with rheumatoid arthritis. 2010
Bisphosphonate associated osteonecrosis of the jaw. 2009
Type I Interferons in Autoimmunity: Implications in Clinical Phenotypes and Treatment Response. 2023
Management of Concomitant Inflammatory Bowel Disease or Uveitis in Patients with Psoriatic Arthritis: An Updated Review Informing the 2021 GRAPPA Treatment Recommendations. 2022
Disparities in Outcomes for African Americans and Whites Undergoing Total Knee Arthroplasty: A Systematic Literature Review. 2016
A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs. 2002
Methotrexate-induced liver abnormalities in rheumatoid arthritis. 1989

VIVO Weill Cornell Medical College

The Journal of rheumatology Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)